Prof.Dr.med. ID: 6488383
Katja Weisel
Publications
- 2022
Prognostic value of minimal residual disease negativity in myeloma: combined analysis of POLLUX, CASTOR, ALCYONE, MAIA
Cavo, M., San-Miguel, J. F. F., Usmani, S. Z., Weisel, K. C., Dimopoulos, M. A. A., Avet-Loiseau, H., Paiva, B., Bahlis, N. J., Plesner, T., Hungria, V. T. D. M., Moreau, P., Mateos, M. V., Perrot, A., Iida, S., Facon, T., Kumar, S. K., van de Donk, N. W. C. J., Sonneveld, P., Spencer, A., Krevvata, M., Heuck, C., Wang, J., Ukropec, J., Kobos, R., Sun, S., Qi, M. & Munshi, N. C., 10.02.2022, In: BLOOD. 139, 6, p. 835-844 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Comparative effectiveness of ciltacabtagene autoleucel in CARTITUDE-1 versus physician's choice of therapy in the Flatiron Health multiple myeloma cohort registry for the treatment of patients with relapsed or refractory multiple myeloma
Martin, T., Krishnan, A., Yong, K., Weisel, K., Mehra, M., Nair, S., Qi, K., Londhe, A., Diels, J., Crivera, C., Jackson, C. C., Olyslager, Y., Vogel, M., Schecter, J. M., Banerjee, A., Valluri, S., Usmani, S. Z., Berdeja, J. G. & Jagannath, S., 02.2022, In: EJHaem. 3, 1, p. 97-108 12 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
MCT1 is a Predictive Marker for Lenalidomide Maintenance Therapy in Multiple Myeloma
Stroh, J., Seckinger, A., Heider, M., Rudelius, M., Eichner, R., Schick, M., Slawska, J., Emde, M., Salwender, H., Bertsch, U., Goldschmidt, H., Weisel, K. C., Scheid, C., Keller, U., Hose, D. & Bassermann, F., 25.01.2022, In: BLOOD ADV. 6, 2, p. 515-520 6 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 vs Physician's Choice of Therapy in the Long-Term Follow-Up of POLLUX, CASTOR, and EQUULEUS Clinical Trials for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Weisel, K., Martin, T., Krishnan, A., Jagannath, S., Londhe, A., Nair, S., Diels, J., Vogel, M., Schecter, J. M., Banerjee, A., Berdeja, J. G., Nesheiwat, T., Garrett, A., Qi, K., Valluri, S., Usmani, S. Z. & Yong, K., 01.2022, In: CLIN DRUG INVEST. 42, 1, p. 29-41 13 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: a subanalysis of OPTIMISMM by clinical characteristics
Richardson, P. G., Schjesvold, F., Weisel, K., Moreau, P., Anderson, L. D., White, D., Rodriguez-Otero, P., Sonneveld, P., Engelhardt, M., Jenner, M., Corso, A., Dürig, J., Pavic, M., Salomo, M., Beksac, M., Oriol, A., Lindsay, J., Liberati, A. M., Galli, M., Robak, P., Larocca, A., Yagci, M., Vural, F., Kanate, A. S., Jiang, R., Grote, L., Peluso, T. & Dimopoulos, M., 01.2022, In: EUR J HAEMATOL. 108, 1, p. 73-83 11 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
CD38-specific nanobodies allow in vivo imaging of multiple myeloma under daratumumab therapy
Pape, L. J., Hambach, J., Gebhardt, A. J., Rissiek, B., Stähler, T., Tode, N., Khan, C., Weisel, K., Adam, G., Koch-Nolte, F. & Bannas, P., 2022, In: FRONT IMMUNOL. 13, 1010270.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Half-Life Extended Nanobody-Based CD38-Specific Bispecific Killercell Engagers Induce Killing of Multiple Myeloma Cells
Hambach, J., Fumey, W., Stähler, T., Gebhardt, A. J., Adam, G., Weisel, K., Koch-Nolte, F. & Bannas, P., 2022, In: FRONT IMMUNOL. 13, 838406.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Identification of New Antibodies Targeting Malignant Plasma Cells for Immunotherapy by Next-Generation Sequencing-Assisted Phage Display
Krohn, S., Boje, A. S., Gehlert, C. L., Lutz, S., Darzentas, N., Knecht, H., Herrmann, D., Brüggemann, M., Scheidig, A. J., Weisel, K., Gramatzki, M., Peipp, M. & Klausz, K., 2022, In: FRONT IMMUNOL. 13, 908093.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2021
COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network
Ludwig, H., Sonneveld, P., Facon, T., San-Miguel, J., Avet-Loiseau, H., Mohty, M., Mateos, M-V., Moreau, P., Cavo, M., Pawlyn, C., Zweegman, S., Engelhardt, M., Driessen, C., Cook, G., Dimopoulos, M. A., Gay, F., Einsele, H., Delforge, M., Caers, J., Weisel, K., Jackson, G., Garderet, L., van de Donk, N., Leleu, X., Goldschmidt, H., Beksac, M., Nijhof, I., Schreder, M., Abildgaard, N., Hajek, R., Zojer, N., Kastritis, E., Broijl, A., Schjesvold, F., Boccadoro, M. & Terpos, E., 12.2021, In: LANCET HAEMATOL. 8, 12, p. e934-e946Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Health-related quality of life outcomes from the CANDOR study in patients with relapsed or refractory multiple myeloma
Siegel, D., Weisel, K., Zahlten-Kumeli, A., Medhekar, R., Ding, B. & Leleu, X., 12.2021, In: LEUKEMIA LYMPHOMA. 62, 12, p. 3002-3010 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Lymphocytopenia and Anti-CD38 Directed Treatment Impact the Serological SARS-CoV-2 Response after Prime Boost Vaccination in Patients with Multiple Myeloma
Ghandili, S., Schönlein, M., Wiessner, C., Becher, H., Lütgehetmann, M., Brehm, T. T., Wiesch, J. S. Z., Bokemeyer, C., Sinn, M., Weisel, K. C. & Leypoldt, L., 24.11.2021, In: J CLIN MED. 10, 23, 5499.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Current Treatment Approaches to Newly Diagnosed Multiple Myeloma
Ghandili, S., Weisel, K. C., Bokemeyer, C. & Leypoldt, L. B., 16.11.2021, In: ONCOL RES TREAT. 44, 12, p. 690-699 10 p.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Longer term outcomes with single-agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13-month follow-up from the pivotal DREAMM-2 study
Lonial, S., Lee, H. C., Badros, A., Trudel, S., Nooka, A. K., Chari, A., Abdallah, A-O., Callander, N., Sborov, D., Suvannasankha, A., Weisel, K., Voorhees, P. M., Womersley, L., Baron, J., Piontek, T., Lewis, E., Opalinska, J., Gupta, I. & Cohen, A. D., 15.11.2021, In: CANCER-AM CANCER SOC. 127, 22, p. 4198-4212 15 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Bone Marrow-Resident Vδ1 T Cells Co-express TIGIT With PD-1, TIM-3 or CD39 in AML and Myeloma
Brauneck, F., Weimer, P., Schulze zur Wiesch, J., Weisel, K. C., Leypoldt, L. B., Vohwinkel, G., Fritzsche, B., Bokemeyer, C., Wellbrock, J. & Fiedler, W., 08.11.2021, In: FRONT MED-LAUSANNE. 8, p. 763773 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial
Facon, T., Kumar, S. K., Plesner, T., Orlowski, R. Z., Moreau, P., Bahlis, N., Basu, S., Nahi, H., Hulin, C., Quach, H., Goldschmidt, H., O'Dwyer, M., Perrot, A., Venner, C. P., Weisel, K., Mace, J. R., Raje, N., Tiab, M., Macro, M., Frenzel, L., Leleu, X., Ahmadi, T., Wang, J., Van Rampelbergh, R., Uhlar, C. M., Tromp, B., Delioukina, M., Vermeulen, J. & Usmani, S. Z., 11.2021, In: LANCET ONCOL. 22, 11, p. 1582-1596 15 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial
Salwender, H., Elmaagacli, A., Merz, M., Miah, K., Benner, A., Haenel, M., Jehn, C., Mai, E. K., Bertsch, U., Blau, I. W., Scheid, C., Hose, D., Seckinger, A., Jauch, A., Raab, M. S., Luntz, S. P., Besemer, B., Munder, M., Brossart, P., Fuhrmann, S., Lindemann, H-W., Weisel, K., Duerig, J. & Goldschmidt, H., 10.2021, In: LEUKEMIA. 35, 10, p. 3007-3011 5 p.Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
Matching adjusted indirect comparisons of efficacy outcomes for idecabtagene vicleucel (ide-cel, bb2121) versus selinexor + dexamethasone and belantamab mafodotin in relapsed and refractory multiple myeloma
Rodriguez-Otero, P., Ayers, D., Cope, S., Davies, F. E., Delforge, M., Mojebi, A., Jansen, J. P., Weisel, K., Hege, K. & Dhanasiri, S., 10.2021, In: LEUKEMIA LYMPHOMA. 62, 10, p. 2482-2491 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial
Klein, E-M., Tichy, D., Salwender, H. J., Mai, E. K., Duerig, J., Weisel, K. C., Benner, A., Bertsch, U., Akhavanpoor, M., Besemer, B., Munder, M., Lindemann, H-W., Hose, D., Seckinger, A., Luntz, S., Jauch, A., Elmaagacli, A., Fuhrmann, S., Brossart, P., Goerner, M., Bernhard, H., Raab, M. S., Blau, I. W., Haenel, M., Scheid, C., Goldschmidt, H. & On Behalf Of The German-Speaking Myeloma Multicenter Group Gmmg, 28.09.2021, In: CANCERS. 13, 19, p. 4856Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Improving outcomes for patients with relapsed multiple myeloma: Challenges and considerations of current and emerging treatment options
Ramasamy, K., Gay, F., Weisel, K., Zweegman, S., Mateos, M. V. & Richardson, P., 09.2021, In: Blood reviews. 49, p. 100808Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US
Davies, F., Rifkin, R., Costello, C., Morgan, G., Usmani, S., Abonour, R., Palumbo, A., Romanus, D., Hajek, R., Terpos, E., Cherepanov, D., Stull, D. M., Huang, H., Leleu, X., Berdeja, J., Lee, H. C., Weisel, K., Thompson, M., Boccadoro, M., Zonder, J., Cook, G., Puig, N., Vela-Ojeda, J., Farrelly, E., Raju, A., Blazer, M. & Chari, A., 09.2021, In: ANN HEMATOL. 100, 9, p. 2325-2337 13 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Selective elimination of immunosuppressive T cells in patients with multiple myeloma
Awwad, M. H. S., Mahmoud, A., Bruns, H., Echchannaoui, H., Kriegsmann, K., Lutz, R., Raab, M. S., Bertsch, U., Munder, M., Jauch, A., Weisel, K., Maier, B., Weinhold, N., Salwender, H. J., Eckstein, V., Hänel, M., Fenk, R., Dürig, J., Brors, B., Benner, A., Müller-Tidow, C., Goldschmidt, H. & Hundemer, M., 09.2021, In: LEUKEMIA. 35, 9, p. 2602-2615 14 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Carfilzomib, dexamethasone and daratumumab in relapsed or refractory multiple myeloma: results of the phase III study CANDOR by prior lines of therapy
Quach, H., Nooka, A., Samoylova, O., Venner, C. P., Kim, K., Facon, T., Spencer, A., Usmani, S. Z., Grosicki, S., Suzuki, K., Delimpasi, S., Weisel, K., Obreja, M., Zahlten-Kumeli, A. & Mateos, M-V., 08.2021, In: BRIT J HAEMATOL. 194, 4, p. 784-788 5 p.Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patients with Multiple Myeloma Correlates with Low CD19+ B-Lymphocyte Count and Anti-CD38 Treatment
Ghandili, S., Schönlein, M., Lütgehetmann, M., Wiesch, J. S. Z., Becher, H., Bokemeyer, C., Sinn, M., Weisel, K. C. & Leypoldt, L. B., 28.07.2021, In: CANCERS. 13, 15, 3800.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Outcome of a Real-World Patient Cohort with Secondary CNS Lymphoma Treated with High-Intensity Chemoimmunotherapy and Autologous Stem Cell Transplantation
Thiele, B., Binder, M., Schliffke, S., Frenzel, C., Dierlamm, J., Wass, M., Weisel, K. C., Bokemeyer, C. & Janjetovic, S., 21.07.2021, In: ONCOL RES TREAT. 44, 7-8, p. 375-381 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
56/m mit Rückenschmerzen und Konzentrationsstörungen
Leypoldt, L. B. & Weisel, K. C., 12.07.2021, In: ONKOLOGE. 2021, 27 supplement issue 1, p. 27-32Research output: SCORING: Contribution to journal › SCORING: Journal article › Education
Ixazomib-lenalidomide-dexamethasone in routine clinical practice:effectiveness in relapsed/refractory multiple myeloma
Hájek, R., Minařík, J., Straub, J., Pour, L., Jungova, A., Berdeja, J. G., Boccadoro, M., Brozova, L., Spencer, A., Rhee, F. V., Vela-Ojeda, J., Thompson, M. A., Abonour, R., Chari, A., Cook, G., Costello, C. L., Davies, F. E., Hungria, V. T., Lee, H. C., Leleu, X., Puig, N., Rifkin, R. M., Terpos, E., Usmani, S. Z., Weisel, K. C., Zonder, J. A., Bařinová, M., Kuhn, M., Šilar, J., Čápková, L., Galvez, K., Lu, J., Elliott, J., Stull, D. M., Ren, K. & Maisnar, V., 07.2021, In: FUTURE ONCOL. 17, 19, p. 2499-2512 14 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Belantamab mafodotin in combination with novel agents in relapsed/refractory multiple myeloma: DREAMM-5 study design
Nooka, A. K., Weisel, K., van de Donk, N. W., Routledge, D., Otero, P. R., Song, K., Quach, H., Callander, N., Minnema, M. C., Trudel, S., Jackson, N. A., Ahlers, C. M., Im, E., Cheng, S., Smith, L., Hareth, N., Ferron-Brady, G., Brouch, M., de Oca, R. M., Paul, S., Holkova, B., Gupta, I., Kremer, B. E. & Richardson, P., 06.2021, In: FUTURE ONCOL. 17, 16, p. 1987-2003 17 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Efficacy and safety profile of deep responders to carfilzomib-based therapy: a subgroup analysis from ASPIRE and ENDEAVOR
Weisel, K., Mateos, M-V., Gay, F., Delforge, M., Cook, G., Szabo, Z., Desgraz, R., DeCosta, L. & Moreau, P., 06.2021, In: LEUKEMIA. 35, 6, p. 1732-1744 13 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse
Dimopoulos, M., Weisel, K., Moreau, P., Anderson, L. D., White, D., San-Miguel, J., Sonneveld, P., Engelhardt, M., Jenner, M., Corso, A., Dürig, J., Pavic, M., Salomo, M., Casal, E., Srinivasan, S., Yu, X., Nguyen, T. V., Biyukov, T., Peluso, T. & Richardson, P., 06.2021, In: LEUKEMIA. 35, 6, p. 1722-1731 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Health-related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial
Hungria, V., Beksac, M., Weisel, K. C., Nooka, A. K., Masszi, T., Spicka, I., Munder, M., Mateos, M-V., Mark, T. M., Qi, M., Qin, X., Fastenau, J., Spencer, A., Sonneveld, P., Garvin, W., Renaud, T. & Gries, K. S., 05.2021, In: BRIT J HAEMATOL. 193, 3, p. 561-569 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Evaluation of Sustained Minimal Residual Disease Negativity With Daratumumab-Combination Regimens in Relapsed and/or Refractory Multiple Myeloma: Analysis of POLLUX and CASTOR
Avet-Loiseau, H., San-Miguel, J., Casneuf, T., Iida, S., Lonial, S., Usmani, S. Z., Spencer, A., Moreau, P., Plesner, T., Weisel, K., Ukropec, J., Chiu, C., Trivedi, S., Amin, H., Krevvata, M., Ramaswami, P., Qin, X., Qi, M., Sun, S., Qi, M., Kobos, R. & Bahlis, N. J., 01.04.2021, In: J CLIN ONCOL. 39, 10, p. 1139-1149 11 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma: the randomized GMMG phase III trial ReLApsE
Goldschmidt, H., Baertsch, M-A., Schlenzka, J., Becker, N., Habermehl, C., Hielscher, T., Raab, M-S., Hillengass, J., Sauer, S., Müller-Tidow, C., Luntz, S., Jauch, A., Hose, D., Seckinger, A., Brossart, P., Goerner, M., Klein, S., Schmidt-Hieber, M., Reimer, P., Graeven, U., Fenk, R., Haenel, M., Martin, H., Lindemann, H. W., Scheid, C., Nogai, A., Salwender, H., Noppeney, R., Besemer, B., Weisel, K. & German Myeloma Multicenter Group (GMMG), 04.2021, In: LEUKEMIA. 35, 4, p. 1134-1144 11 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma
Radocha, J., van de Donk, N. W. C. J. & Weisel, K., 29.03.2021, In: CANCERS. 13, 7, p. 1551Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age
Mai, E. K., Miah, K., Bertsch, U., Dürig, J., Scheid, C., Weisel, K. C., Kunz, C., Munder, M., Lindemann, H-W., Merz, M., Hose, D., Jauch, A., Seckinger, A., Luntz, S., Sauer, S., Fuhrmann, S., Brossart, P., Elmaagacli, A., Goerner, M., Bernhard, H., Hoffmann, M., Raab, M. S., Blau, I. W., Hänel, M., Benner, A., Salwender, H. J., Goldschmidt, H. & German-speaking Myeloma Multicenter Group (GMMG), 03.2021, In: LEUKEMIA. 35, 3, p. 809-822 14 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
Moreau, P., Kumar, S. K., San Miguel, J., Davies, F., Zamagni, E., Bahlis, N., Ludwig, H., Mikhael, J., Terpos, E., Schjesvold, F., Martin, T., Yong, K., Durie, B. G. M., Facon, T., Jurczyszyn, A., Sidana, S., Raje, N., van de Donk, N., Lonial, S., Cavo, M., Kristinsson, S. Y., Lentzsch, S., Hajek, R., Anderson, K. C., João, C., Einsele, H., Sonneveld, P., Engelhardt, M., Fonseca, R., Vangsted, A., Weisel, K., Baz, R., Hungria, V., Berdeja, J. G., Leal da Costa, F., Maiolino, A., Waage, A., Vesole, D. H., Ocio, E. M., Quach, H., Driessen, C., Bladé, J., Leleu, X., Riva, E., Bergsagel, P. L., Hou, J., Chng, W. J., Mellqvist, U-H., Dytfeld, D., Harousseau, J-L., Goldschmidt, H., Laubach, J., Munshi, N. C., Gay, F., Beksac, M., Costa, L. J., Kaiser, M., Hari, P., Boccadoro, M., Usmani, S. Z., Zweegman, S., Holstein, S., Harrison, S., Nahi, H., Cook, G., Mateos, M-V., Rajkumar, S. V., Dimopoulos, M. A. & Richardson, P. G., 03.2021, In: LANCET ONCOL. 22, 3, p. e105-e118Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Munshi, N. C., Anderson, L. D., Shah, N., Madduri, D., Berdeja, J., Lonial, S., Raje, N., Lin, Y., Siegel, D., Oriol, A., Moreau, P., Yakoub-Agha, I., Delforge, M., Cavo, M., Einsele, H., Goldschmidt, H., Weisel, K., Rambaldi, A., Reece, D., Petrocca, F., Massaro, M., Connarn, J. N., Kaiser, S., Patel, P., Huang, L., Campbell, T. B., Hege, K. & San-Miguel, J., 25.02.2021, In: NEW ENGL J MED. 384, 8, p. 705-716 12 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life
Terpos, E., Mikhael, J., Hajek, R., Chari, A., Zweegman, S., Lee, H. C., Mateos, M-V., Larocca, A., Ramasamy, K., Kaiser, M., Cook, G., Weisel, K. C., Costello, C. L., Elliott, J., Palumbo, A. & Usmani, S. Z., 18.02.2021, In: BLOOD CANCER J. 11, 2, p. 40Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Evaluation of Cardiac Repolarization in the Randomized Phase 2 Study of Intermediate- or High-Risk Smoldering Multiple Myeloma Patients Treated with Daratumumab Monotherapy
Chari, A., Munder, M., Weisel, K., Jenner, M., Bygrave, C., Petrucci, M. T., Boccadoro, M., Cavo, M., van de Donk, N. W. C. J., Turgut, M., Demirkan, F., Karadogan, I., Libby, E., Kleiman, R., Kuppens, S., Bandekar, R., Neff, T., Heuck, C., Qi, M., Clemens, P. L. & Goldschmidt, H., 02.2021, In: ADV THER. 38, 2, p. 1328-1341 14 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Front-line daratumumab-VTd versus standard-of-care in ASCT-eligible multiple myeloma: matching-adjusted indirect comparison
Moreau, P., Hebraud, B., Facon, T., Leleu, X., Hulin, C., Hashim, M., Hu, Y., Caillot, D., Benboubker, L., Zweegman, S., Merz, M., Weisel, K., Salwender, H., Mai, E. K., Goldschmidt, H., Bertsch, U., Vanquickelberghe, V., Kampfenkel, T., Boer, C. D., Krotneva, S., Proskorovsky, I., He, J., Lam, A., Lee, C., Cote, S. & Sonneveld, P., 02.2021, In: IMMUNOTHERAPY-UK. 13, 2, p. 143-154 12 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial
Perrot, A., Facon, T., Plesner, T., Usmani, S. Z., Kumar, S., Bahlis, N. J., Hulin, C., Orlowski, R. Z., Nahi, H., Mollee, P., Ramasamy, K., Roussel, M., Jaccard, A., Delforge, M., Karlin, L., Arnulf, B., Chari, A., He, J., Ho, K. F., Van Rampelbergh, R., Uhlar, C. M., Wang, J., Kobos, R., Gries, K. S., Fastenau, J. & Weisel, K., 20.01.2021, In: J CLIN ONCOL. 39, 3, p. 227-237 11 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Baertsch, M-A., Mai, E. K., Hielscher, T., Bertsch, U., Salwender, H. J., Munder, M., Fuhrmann, S., Dührsen, U., Brossart, P., Neben, K., Schlenzka, J., Kunz, C., Raab, M. S., Hillengaß, J., Jauch, A., Seckinger, A., Hose, D., Luntz, S., Sonneveld, P., Lokhorst, H., Martin, H., Goerner, M., Hoffmann, M., Lindemann, H-W., Bernhard, H., Blau, I. W., Scheid, C., Besemer, B., Weisel, K. C., Hänel, M., Dürig, J., Goldschmidt, H. & German-speaking Myeloma Multicenter Group (GMMG), 07.01.2021, In: BLOOD CANCER J. 11, 1, p. 1Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network
Ludwig, H., Boccadoro, M., Moreau, P., San-Miguel, J., Cavo, M., Pawlyn, C., Zweegman, S., Facon, T., Driessen, C., Hajek, R., Dimopoulos, M. A., Gay, F., Avet-Loiseau, H., Terpos, E., Zojer, N., Mohty, M., Mateos, M-V., Einsele, H., Delforge, M., Caers, J., Weisel, K., Jackson, G., Garderet, L., Engelhardt, M., van de Donk, N., Leleu, X., Goldschmidt, H., Beksac, M., Nijhof, I., Abildgaard, N., Bringhen, S. & Sonneveld, P., 01.2021, In: LEUKEMIA. 35, 1, p. 31-44 14 p.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
- 2020
Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients
Ghandili, S., Pfefferle, S., Roedl, K., Sonnemann, P., Karagiannis, P., Boenisch, O., Kluge, S., Schmiedel, S., Ittrich, H., Rohde, H., Lütgehetmann, M., Weisel, K., Bokemeyer, C., Wichmann, D., Fiedler, W., Jarczak, D. & Modemann, F., 08.12.2020, In: Blood Adv. 4, 23, p. 5936-5941 6 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Efficacy and safety of carfilzomib-based regimens in frail patients with relapsed and/or refractory multiple myeloma
Facon, T., Niesvizky, R., Mateos, M-V., Siegel, D., Rosenbaum, C., Bringhen, S., Weisel, K., Ho, P. J., Ludwig, H., Kumar, S., Wang, K., Obreja, M., Yang, Z., Klippel, Z., Mezzi, K., Goldrick, A., Tekle, C. & Dimopoulos, M. A., 10.11.2020, In: BLOOD ADV. 4, 21, p. 5449-5459 11 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Clinical Features Associated with COVID-19 Outcome in MM: First Results from International Myeloma Society Dataset
Chari, A., Samur, M. K., Martinez-Lopez, J., Cook, G., Biran, N., Yong, K. L., Hungria, V. T. D. M., Engelhardt, M., Gay, F., Garcia-Feria, A., Oliva, S., Oostvogels, R., Gozzetti, A., Rosenbaum, C. A., Kumar, S. K., Stadtmauer, E., Einsele, H., Beksac, M., Weisel, K. C., Anderson, K. C., Mateos, M-V., Moreau, P., San Miguel, J., Munshi, N. C. & Avet-Loiseau, H., 06.11.2020, In: BLOOD.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myeloma
Goldschmidt, H., Dimopoulos, M. A., Rajkumar, S. V., Weisel, K. C., Moreau, P., Chng, W-J., Mikala, G., Cavo, M., Ramasamy, K., Suryanarayan, K., Teng, Z., Labotka, R. & Mateos, M. V., 11.2020, In: LEUKEMIA. 34, 11, p. 3019-3027 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Early M-protein Dynamics Predicts Progression-Free Survival in Patients With Relapsed/Refractory Multiple Myeloma
Yan, X., Xu, X. S., Weisel, K. C., Mateos, M-V., Sonneveld, P., Dimopoulos, M. A., Usmani, S. Z., Bahlis, N. J., Puchalski, T., Ukropec, J., Bellew, K., Ming, Q., Sun, S. & Zhou, H., 11.2020, In: CTS-CLIN TRANSL SCI. 13, 6, p. 1345-1354 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Autologous stem cell transplantation in multiple myeloma patients: utilization patterns and hospital effects
Jansen, L., Merz, M., Engelhardt, M., Weisel, K., Scheid, C., Straka, C., Langer, C., Salwender, H., Einsele, H., Kröger, N., Beelen, D. W., Dreger, P., Goldschmidt, H., Brenner, H. & German National Registry for Stem Cell Transplants (DRST), 10.2020, In: LEUKEMIA LYMPHOMA. 61, 10, p. 2365-2374 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study
Dimopoulos, M. A., Lonial, S., White, D., Moreau, P., Weisel, K., San-Miguel, J., Shpilberg, O., Grosicki, S., Špička, I., Walter-Croneck, A., Magen, H., Mateos, M-V., Belch, A., Reece, D., Beksac, M., Spencer, A., Oakervee, H., Orlowski, R. Z., Taniwaki, M., Röllig, C., Einsele, H., Matsumoto, M., Wu, K. L., Anderson, K. C., Jou, Y-M., Ganetsky, A., Singhal, A. K. & Richardson, P. G., 04.09.2020, In: BLOOD CANCER J. 10, 9, p. 91Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials
Gavriatopoulou, M., Chari, A., Chen, C., Bahlis, N., Vogl, D. T., Jakubowiak, A., Dingli, D., Cornell, R. F., Hofmeister, C. C., Siegel, D., Berdeja, J. G., Reece, D., White, D., Lentzsch, S., Gasparetto, C., Huff, C. A., Jagannath, S., Baz, R., Nooka, A. K., Richter, J., Abonour, R., Parker, T. L., Yee, A. J., Moreau, P., Lonial, S., Tuchman, S., Weisel, K. C., Mohty, M., Choquet, S., Unger, T. J., Li, K., Chai, Y., Li, L., Shah, J., Shacham, S., Kauffman, M. G. & Dimopoulos, M. A., 09.2020, In: LEUKEMIA. 34, 9, p. 2430-2440 11 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review